Pitcairn CO Sarepta Therapeutics, Inc. Transaction History

Pitcairn CO

$1.67 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$113.33 - $163.85 $186,427 - $269,533	1,645 New	1,645 $259,000
Q3 2023 Nov 13, 2023	BUY	$102.5 - $123.59 $2,152 - $2,595	21 Added 0.75%	2,822 $342,000
Q2 2023 Aug 11, 2023	SELL	$106.4 - $157.19 $286,960 - $423,941	-2,697 Reduced 49.05%	2,801 $320,000
Q1 2023 May 05, 2023	SELL	$117.53 - $155.99 $84,504 - $112,156	-719 Reduced 11.57%	5,498 $757,000
Q4 2022 Feb 13, 2023	SELL	$100.86 - $132.13 $27,837 - $36,467	-276 Reduced 4.25%	6,217 $805,000
Q3 2022 Nov 10, 2022	SELL	$75.71 - $119.24 $64,126 - $100,996	-847 Reduced 11.54%	6,493 $718,000
Q2 2022 Aug 12, 2022	BUY	$62.69 - $88.44 $4,262 - $6,013	68 Added 0.94%	7,340 $550,000
Q1 2022 May 12, 2022	BUY	$63.15 - $90.42 $66,118 - $94,669	1,047 Added 16.82%	7,272 $568,000
Q4 2021 Feb 14, 2022	SELL	$77.28 - $99.42 $46,599 - $59,950	-603 Reduced 8.83%	6,225 $561,000
Q3 2021 Nov 10, 2021	SELL	$65.97 - $92.48 $62,473 - $87,578	-947 Reduced 12.18%	6,828 $631,000
Q2 2021 Aug 11, 2021	BUY	$69.38 - $86.75 $321,715 - $402,259	4,637 Added 147.77%	7,775 $604,000
Q1 2021 May 10, 2021	BUY	$72.25 - $168.95 $83,159 - $194,461	1,151 Added 57.93%	3,138 $234,000
Q4 2020 Feb 05, 2021	SELL	$125.56 - $178.74 $22,726 - $32,351	-181 Reduced 8.35%	1,987 $339,000
Q3 2020 Nov 03, 2020	SELL	$127.12 - $172.34 $36,991 - $50,150	-291 Reduced 11.83%	2,168 $305,000
Q2 2020 Jul 28, 2020	BUY	$93.0 - $171.7 $26,505 - $48,934	285 Added 13.11%	2,459 $394,000
Q1 2020 May 13, 2020	SELL	$82.38 - $131.64 $52,887 - $84,512	-642 Reduced 22.8%	2,174 $213,000
Q4 2019 Feb 12, 2020	BUY	$76.53 - $135.58 $215,508 - $381,793	2,816 New	2,816 $363,000
Q3 2019 Nov 12, 2019	SELL	$72.81 - $156.91 $137,246 - $295,775	-1,885 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$112.21 - $151.95 $15,036 - $20,361	-134 Reduced 6.64%	1,885 $286,000
Q1 2019 May 07, 2019	BUY	$106.67 - $151.68 $215,366 - $306,241	2,019 New	2,019 $240,000

Others Institutions Holding SRPT

# of Institutions

525

Shares Held

84.4M

Call Options Held

2.06M

Put Options Held

1.52M

Black Rock Inc. New York, NY

10.3M
Shares

$1.17 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

8.97M
Shares

$1.02 Billion
0.02% of portfolio
Capital International Investors Los Angeles, CA

6.26M
Shares

$712 Million
0.16% of portfolio
Janus Henderson Group PLC London, X0

4.36M
Shares

$496 Million
0.29% of portfolio
State Street Corp Boston, MA

4.27M
Shares

$486 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.96B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pitcairn CO, based on Form 13F filings with the SEC.

News

Stay updated on Pitcairn CO with notifications on news.

Account